(Q40639031)

English

Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides

scientific article published on September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

0 references

author name string

Amelia K Petch

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Muhammad Sohail

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Marcus D Hughes

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Ibrahim Benter

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

John Darling

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Edwin M Southern

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Saghir Akhtar

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

819-830

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

The cellular delivery of antisense oligonucleotides and ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Antisense technology: selection and delivery of optimally acting antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Sequence-specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Receptor tyrosine kinases as targets for anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Nuclear localization of EGF receptor and its potential new role as a transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Epidermal growth factor receptor dependence in human tumors: more than just expression?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Why the epidermal growth factor receptor? The rationale for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Sequence and chemistry requirements for a novel aptameric oligonucleotide inhibitor of EGF receptor tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Synthetic 2'-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Using oligonucleotide scanning arrays to find effective antisense reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

The folding of large RNAs studied by hybridization to arrays of complementary oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

eps15, a novel tyrosine kinase substrate, exhibits transforming activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Eps15 is recruited to the plasma membrane upon epidermal growth factor receptor activation and localizes to components of the endocytic pathway during receptor internalization.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Antagonistic effects of protein kinase C alpha and delta on both transformation and phospholipase D activity mediated by the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Stimulation of phospholipase D by epidermal growth factor requires protein kinase C activation in Swiss 3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Epidermal growth factor receptor-targeted therapy in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Antisense DNAs as multisite genomic modulators identified by DNA microarray

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Evaluating the specificity of antisense oligonucleotide conjugates. A DNA array analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Antisense oligonucleotides to the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Treatment of the T98G glioblastoma cell line with antisense oligonucleotides directed toward mRNA encoding transforming growth factor-alpha and the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

The delivery of antisense therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Antisense arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Selecting effective antisense reagents on combinatorial oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Determining the influence of structure on hybridization using oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

Studies on uptake, sub-cellular trafficking and efflux of antisense oligodeoxynucleotides in glioma cells using self-assembling cationic lipoplexes as delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900407-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-2952(03)00407-6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40639031&oldid=1904047055"